Today’s clinical trial landscape offers an unprecedented range of decentralized and hybrid options, including home health and community-based options. Digital solutions have been hailed as the path toward more inclusive trials yet many still struggle to recruit representative patient populations, despite clear regulatory guidance. How can the feedback from participants in recent clinical trials help industry refine its DCT approach to be even more inclusive and responsive to patient preferences? How can industry work more collaboratively with advocates who possess distinct lines of site into their communities’ needs and experiences around trial participation?
The Patient Choice Centered Research Initiative (PCCRI) asked recent clinical trial participants across a range of patient communities to reflect on their satisfaction with the operational aspects of their trial experience through a 50-question survey. PCCRI then collaborated with five patient advocacy groups with distinct patient population needs to analyze the findings alongside what they’ve heard from their own communities to turn insights into actionable, feasible DCT strategies that align to patient choice.
This webinar will address how insights from this initiative and other patient-focused efforts can help to close geographic and digital health literacy gaps, decrease trial-related financial toxicities, and minimize burden for sites and patients.
Keri McDonough, Head, Patient Voice Consortium & Vice President, Medical and Scientific Strategy, Syneos Health
Nicole Hemmenway CEO, U.S. Pain Foundation
, Associate Director, Site & Patient Experience, Syneos Health
, Associate Director, Decentralized Clinical Trials, Syneos Health